Friday, January 26, 2018


FDA Continues to Prioritize Compounding Regulation with the 2018Compounding Policy Priorities ...
A component of the Federal Food, Drug and Cosmetic Act (FD&C Act) is the restrictions it places on compounding drugs that are essentially copies of FDA-approved or commercially available products. On January 19, 2018, FDA issued two final guidance documents regarding the copies provisions for ...
Post a Comment